Details for New Drug Application (NDA): 209307
✉ Email this page to a colleague
The generic ingredient in DEXMEDETOMIDINE HYDROCHLORIDE is dexmedetomidine hydrochloride. There are fourteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the dexmedetomidine hydrochloride profile page.
Summary for 209307
| Tradename: | DEXMEDETOMIDINE HYDROCHLORIDE |
| Applicant: | Gland |
| Ingredient: | dexmedetomidine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 209307
| Mechanism of Action | Adrenergic alpha2-Agonists |
| Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for 209307
Suppliers and Packaging for NDA: 209307
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 209307 | ANDA | Sagent Pharmaceuticals | 25021-617 | 25021-617-82 | 20 BAG in 1 CARTON (25021-617-82) / 100 mL in 1 BAG |
| DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 209307 | ANDA | Dr.Reddy's Laboratories Inc | 43598-975 | 43598-975-58 | 10 VIAL in 1 CARTON (43598-975-58) / 100 mL in 1 VIAL (43598-975-11) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML) | ||||
| Approval Date: | Jun 3, 2020 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) | ||||
| Approval Date: | Jun 3, 2020 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
